April 9 (Reuters) - A U.S. district court has entered into what is known as a consent decree to restrict the production and sale of Philips' new sleep apnea machines and other devices at several facilities in the country until certain requirements are met, the U.S. Food and Drug Administration said on Tuesday. (Reporting by Christy Santhosh; Editing by Maju Samuel)